Citation: | TONGJing, ZHUQing, GUOYao, GUORui, ZHAOFeng-ming, LIWei, LIYu, BIANHui-min. Effects of Liguzinediol on Hemodynamics in Chronic Heart Failure Rats Induced by Doxorubicin[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(2): 166-170. |
[1] |
蔡建国, 李伟, 钱程博,等. Liguzinediol的合成工艺优化[J]. 南京中医药大学学报, 2018, 34(3):322-324.
|
[2] |
徐建虎,张琦,杨子庆,等.阿霉素诱导大鼠慢性心衰模型的制备[J].宁夏医科大学学报, 2016, 38(3):348-351.
|
[3] |
李文文, 徐斌, 童静,等. Liguzinediol对普罗帕酮诱导的急性心衰大鼠心功能的影响[J]. 南京医科大学学报, 2018,38(11):1506-1511,1524.
|
[4] |
郭瑶, 周静, 卞慧敏, 等. 川芎嗪衍生物liguzinediol对戊巴比妥钠致急性心力衰竭大鼠血流动力学的影响[J]. 中国实验方剂学杂志, 2012, 18(6):170-174.
|
[5] |
翟淑波, 孙景辉, 郭放. 充血性心力衰竭发病机制的研究进展[J]. 临床儿科杂志, 2006, 24(10):851-853.
|
[6] |
KNAAPEN MW, DAVIES MJ, DE BM, et al. Apoptotic versus autophagic cell death in heart failure[J]. Cardiovasc Res, 2001, 51(2):304-312.
|
[7] |
WANG S, KONOREV EA, KOTAMRAJU S, et al. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H2O2- and p53-dependent pathways[J]. J Biol Chem, 2004, 279(24):25535-25543.
|
[8] |
AKAO M, O'ROURKE B, TESHIMA Y, et al. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes[J]. Circ Res, 2003, 92(2):186-194.
|
[9] |
金春花, 刘文博, 关宏锏,等. 一氧化氮合酶各种亚型的信号通路对心力衰竭的作用机制与治疗的研究进展[J]. 中国循环杂志, 2017, 32(8):830-832.
|
[10] |
MIHM MJ, YU F, WEINSTEIN DM, et al. Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: Evidence for selective impairment of myofibrillar creatine kinase[J]. Br J Pharmacol, 2002, 135(3):581-588.
|
[11] |
CHICCO AJ, SCHNEIDER CM, HAYWARD R. Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart[J]. Am J Physiol Regul Integr Comp Physiol, 2005, 289(2):R424-R431.
|
[12] |
GIELEN S, ADAMS V, MOBIUSWINKLER S, et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure[J]. J Am Coll Cardiol, 2003, 42(5):861-868.
|